Quantum Biopharma Stock Technical Analysis
| QNTM Stock | 3.42 0.11 3.32% |
As of the 21st of January, Quantum BioPharma holds the Risk Adjusted Performance of (0.12), variance of 35.15, and Coefficient Of Variation of (667.66). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Quantum BioPharma, as well as the relationship between them. Please check Quantum BioPharma mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and kurtosis to decide if Quantum BioPharma is priced some-what accurately, providing market reflects its current price of 3.42 per share. Given that Quantum BioPharma has information ratio of (0.15), we recommend you to check out Quantum BioPharma's recent market performance to make sure the company can sustain itself at a future point.
Quantum BioPharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Quantum, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to QuantumQuantum |
Quantum BioPharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Quantum BioPharma Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Quantum BioPharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Quantum BioPharma Trend Analysis
Use this graph to draw trend lines for Quantum BioPharma. You can use it to identify possible trend reversals for Quantum BioPharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Quantum BioPharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Quantum BioPharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Quantum BioPharma applied against its price change over selected period. The best fit line has a slop of 0.04 , which may suggest that Quantum BioPharma market price will keep on failing further. It has 122 observation points and a regression sum of squares at 63.14, which is the sum of squared deviations for the predicted Quantum BioPharma price change compared to its average price change.About Quantum BioPharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Quantum BioPharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Quantum BioPharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Quantum BioPharma price pattern first instead of the macroeconomic environment surrounding Quantum BioPharma. By analyzing Quantum BioPharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Quantum BioPharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Quantum BioPharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Quantum BioPharma January 21, 2025 Technical Indicators
Most technical analysis of Quantum help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Quantum from various momentum indicators to cycle indicators. When you analyze Quantum charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | (0.53) | |||
| Mean Deviation | 4.15 | |||
| Coefficient Of Variation | (667.66) | |||
| Standard Deviation | 5.93 | |||
| Variance | 35.15 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.93) | |||
| Total Risk Alpha | (1.04) | |||
| Treynor Ratio | (0.54) | |||
| Maximum Drawdown | 29.92 | |||
| Value At Risk | (12.46) | |||
| Potential Upside | 8.01 | |||
| Skewness | (0.13) | |||
| Kurtosis | 1.73 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quantum BioPharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quantum BioPharma. If investors know Quantum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quantum BioPharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Quantum BioPharma is measured differently than its book value, which is the value of Quantum that is recorded on the company's balance sheet. Investors also form their own opinion of Quantum BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Quantum BioPharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quantum BioPharma's market value can be influenced by many factors that don't directly affect Quantum BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quantum BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Quantum BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quantum BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.